Tiagabine [Inn] en es it fr

Tiagabine [Inn] Brand names, Tiagabine [Inn] Analogs

Tiagabine [Inn] Brand Names Mixture

  • No information avaliable

Tiagabine [Inn] Chemical_Formula

C20H25NO2S2

Tiagabine [Inn] RX_link

http://www.rxlist.com/cgi/generic/gabitril.htm

Tiagabine [Inn] fda sheet

Tiagabine_[Inn] FDA

Tiagabine [Inn] msds (material safety sheet)

Tiagabine [Inn] Synthesis Reference

No information avaliable

Tiagabine [Inn] Molecular Weight

375.55 g/mol

Tiagabine [Inn] Melting Point

No information avaliable

Tiagabine [Inn] H2O Solubility

No information avaliable

Tiagabine [Inn] State

Solid

Tiagabine [Inn] LogP

3.417

Tiagabine [Inn] Dosage Forms

No information avaliable

Tiagabine [Inn] Indication

For the treatment of partial seizures

Tiagabine [Inn] Pharmacology

Tiagabine is used primarily as an anticonvulsant for the adjunctive treatment of epilepsy. The precise mechanism by which Tiagabine exerts its antiseizure effect is unknown, although it is believed to be related to its ability to enhance the activity of gamma aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system. Tiagabine binds to recognition sites associated with the GABA uptake carrier. It is thought that, by this action, Tiagabine blocks GABA uptake into presynaptic neurons, permitting more GABA to be available for receptor binding on the surfaces of post-synaptic cells.

Tiagabine [Inn] Absorption

Tiagabine is nearly completely absorbed (>95%).

Tiagabine [Inn] side effects and Toxicity

No information avaliable

Tiagabine [Inn] Patient Information

No information avaliable

Tiagabine [Inn] Organisms Affected

Humans and other mammals